Inside the Gold Rush: Black-Market Peptide Testing and the Race to Cash In on Legalization
By
Amanda Mull, Madison Muller, Ashleigh Furlong
Summary
The article covers the booming black-market peptide and anabolic steroid industry, focusing on Janoshik Analytical, a purity testing company founded by Peter Magic. As these substances move toward mainstream acceptance and potential legalization, entrepreneurs, investors, and healthcare players are racing to capitalize on the multibillion-dollar opportunity. The piece examines the testing infrastructure, regulatory gray areas, and the gold-rush mentality surrounding performance-enhancing drugs going legitimate.
Source
bskyInside the Gold Rush: Black-Market Peptide Testing and the Race to Cash In on Legalizationbloomberg.comKey quotes
· 3 pulledIn an industrial park a half-hour outside Prague, Peter Magic finds himself at the center of a gold rush.
His company, Janoshik Analytical, does purity and sterility testing for black-market anabolic steroids.
As black-market drugs go mainstream and legalization is within reach, entrepreneurs, investors and healthcare players are racing to cash in.
You might also wanna read
Inside the Grey Market Peptide Economy: Regulatory Gaps and Underground Pharmaceutical Infrastructure
This article investigates the parallel pharmaceutical infrastructure built around grey market peptides like BPC-157 and semaglutide. It cont
vectorculture.substack.com·6mo ago
Audio long read: Is the peptide craze backed by science? The promise behind the hype
Inside the BoF and Clinuvel Community Lunch Exploring the Future of Skin Health
businessoffashion.com·12h ago
Interview with Sandoz CEO Richard Saynor on Generic Pharmaceuticals Industry
This article discusses an interview with Richard Saynor, head of Sandoz, focusing on the generic pharmaceuticals industry and its difference
science.org·8mo ago
Guest Essay: Serendipitous Science Like the Gila Monster Discovery That Led to GLP-1 Drugs Is Under Threat
A guest essay argues that funding for "weird" or serendipitous scientific research is under threat, using the example of John Eng's 1990s di
nytimes.com·15d agoGuest Essay: Serendipitous Science Like the Gila Monster Discovery That Led to GLP-1 Drugs Is Under Threat
A guest essay argues that funding for "weird" or serendipitous scientific research is under threat, using the example of John Eng's 1990s di
nytimes.com·15d ago
China's Rise in Global Clinical Trials: Regulatory Reforms and US Competitiveness
Theo Jaffee and Gabriel Dickinson interview Cremieux about China's rapid ascent to global leadership in clinical trial output. The discussio
pca.st·16d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.